Valsartan for prevention of recurrent atrial fibrillation
GISSI-AF Investigators - New England Journal of Medicine, 2009 - Mass Medical Soc
Background Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy
is ideal for control of this condition. Experimental studies suggest that angiotensin II …
is ideal for control of this condition. Experimental studies suggest that angiotensin II …
Valsartan for prevention of recurrent atrial fibrillation
P Delise, F Bertocchi, G Maiocchi, E Geraci… - NEW ENGLAND …, 2009 - iris.unisr.it
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, and no current
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
Valsartan for prevention of recurrent atrial fibrillation
P Delise, F Bertocchi, G Maiocchi, E Geraci… - NEW ENGLAND …, 2009 - air.unimi.it
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, and no current
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
Valsartan for prevention of recurrent atrial fibrillation.
M Disertori, R Latini, A Maggioni, S Barlera… - NEW ENGLAND …, 2009 - flore.unifi.it
Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy is ideal for
control of this condition. Experimental studies suggest that angiotensin II-receptor blockers …
control of this condition. Experimental studies suggest that angiotensin II-receptor blockers …
[引用][C] Valsartan for prevention of recurrent atrial fibrillation
GISSI-AF Investigators - N Engl J Med, 2009 - cir.nii.ac.jp
Valsartan for prevention of recurrent atrial fibrillation.
M Disertori, R Latini, S Barlera… - The New England …, 2009 - europepmc.org
Background Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy
is ideal for control of this condition. Experimental studies suggest that angiotensin II-receptor …
is ideal for control of this condition. Experimental studies suggest that angiotensin II-receptor …
Valsartan for prevention of recurrent atrial fibrillation
M Disertori, R Latini, S Barlera, MG Franzosi… - 2009 - pubmed.ncbi.nlm.nih.gov
Background Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy
is ideal for control of this condition. Experimental studies suggest that angiotensin II-receptor …
is ideal for control of this condition. Experimental studies suggest that angiotensin II-receptor …
Valsartan for prevention of recurrent atrial fibrillation.
M Disertori, R Latini, S Barlera, M Franzosi… - NEW ENGLAND …, 2009 - iris.unina.it
Valsartan for prevention of recurrent atrial fibrillation. IRIS IRIS Home Sfoglia Macrotipologie
& tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo …
& tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo …
Valsartan for prevention of recurrent atrial fibrillation.
M Disertori, R Latini, S Barlera, M Franzosi… - NEW ENGLAND …, 2009 - iris.unimore.it
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, and no current
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
Valsartan for prevention of recurrent atrial fibrillation.
M Disertori, R Latini, S Barlera, M Franzosi… - NEW ENGLAND …, 2009 - iris.uniroma1.it
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, and no current
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …
therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II …